Zobrazeno 1 - 10
of 1 535
pro vyhledávání: '"F. Franceschi"'
Autor:
D. D’Amario, A. Restivo, A. M. Leone, R. Vergallo, S. Migliaro, F. Canonico, M. Galli, C. Trani, F. Burzotta, C. Aurigemma, G. Niccoli, A. Buffon, R. A. Montone, A. Flex, F. Franceschi, G. Tinelli, U. Limbruno, F. Francese, I. Ceccarelli, J. A. Borovac, I. Porto, F. Crea
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-13 (2020)
Abstract Background Ticagrelor is a reversibly binding, direct-acting, oral, P2Y12 antagonist used for the prevention of atherothrombotic events in patients with coronary artery disease (CAD). Ticagrelor blocks adenosine reuptake through the inhibiti
Externí odkaz:
https://doaj.org/article/300c2a79e45b4ff481411287c143774e
Autor:
L. Capurso, F. Franceschi
Publikováno v:
Microbiota in Health and Disease, Vol 3 (2021)
The 11th International meeting Probiotics Prebiotics & New Foods was held in Rome, at Università Urbaniana, from September 12th to 14th 2021. The congress has been attended by 570 people from 36 countries (Algiers, Argentina, Australia, Austria, Bel
Externí odkaz:
https://doaj.org/article/c0ae5e9b55cb4dcf9e7ea43a8db09991
Autor:
G. Menna, G.M. Della Pepa, M. Covino, A.M. Auricchio, F.M. Polli, A. Manno, B. Simeoni, A. Olivi, F. Franceschi
Publikováno v:
Brain and Spine, Vol 1, Iss , Pp 100613- (2021)
Externí odkaz:
https://doaj.org/article/9f25fda8f9904dd6814d94bcab16b32b
Autor:
S. Cicchinelli, E. Nuzzo, F. Franceschi, G. Pignataro, E. Torelli, D. Marchesini, L. Sabia, E. Nista, M. Covino, M. Candelli
Publikováno v:
Microbiota in Health and Disease, Vol 2 (2020)
The effort of the Humane Microbiome Project has led to the awareness that many districts of the human organism, like the skin, gastrointestinal tract, and genitals harbor their normal resident microbes. For this reason, the scientific community overc
Externí odkaz:
https://doaj.org/article/993bbf23ee324180b2a120fe4a4af9c3
Autor:
T. Rokkas, Y. Niv, J. Gisbert, F. Franceschi, A. Gasbarrini, G. Hold, C. O'Morain, P. Malfertheiner, F. Megraud
Publikováno v:
Microbiota in Health and Disease, Vol 2 (2020)
Objective: Recent randomized control trials (RCTs), have demonstrated the beneficial therapeutic effects of rifaximin for the treatment of the irritable bowel syndrome (IBS). However, in these studies different drug doses have been used and still the
Externí odkaz:
https://doaj.org/article/505d19bed0b740aa92003762021261d5
Publikováno v:
Microbiota in Health and Disease, Vol 2 (2020)
Microbiota is the set of microorganisms that compose our microbial community. The human microbiota comprises a vast collection of bacteria, viruses, fungi and protozoa that co-exist with us and establish physio-metabolic interactions with our cellula
Externí odkaz:
https://doaj.org/article/a2c0746d6ca84b95a96b8e2777571bf2
Publikováno v:
Microbiota in Health and Disease, Vol 2 (2020)
In recent years we have seen an exponential growth in scientific research aimed at characterising the structure and composition of the microbiota, which colonises various organs and systems. These investigations were supported by the development of v
Externí odkaz:
https://doaj.org/article/f50d5539882c4228a6ec2c56a1e75159
Publikováno v:
Microbiota in Health and Disease, Vol 2 (2020)
While it is increasingly outlined the link between gut microbiota and several systemic and gastrointestinal diseases, to date the role of the oral microbiota is not well clarified. Different factors like diet, smoke, alcohol, and use of probiotics h
Externí odkaz:
https://doaj.org/article/7cead74185094771b2282146c8100d09
Publikováno v:
Microbiota in Health and Disease, Vol 2 (2020)
Neoplasms are one of the main causes of mortality worldwide. Hepatocellular carcinoma (HCC), oesophageal, gastric, and colorectal cancer represent malignancies with major incidence and impact of the gastrointestinal tract. Unfortunately, patients are
Externí odkaz:
https://doaj.org/article/ed4bed90ec4b426da1bfe528cdaf829a
Publikováno v:
Microbiota in Health and Disease, Vol 1 (2019)
Externí odkaz:
https://doaj.org/article/a97965d4e8904d4b83a78dc2fd336736